蝮蛇抗栓酶合并对症疗法治疗肺心病高粘血症78例

Fushe Kangshuanmei combined heterotherapy for blood hyperviscosity in pulmonary heart disease in 78 patients

肺心病伴高粘血症158例,其中78例(男58例,女20例;年龄59±10a)采用对症疗法合并蝮蛇抗栓酶0.25U,0.50U,0.75U 3种不同剂量加入生理盐水250mL,静滴,qd治疗。另80例(男57例,女23例;年龄61±6a)采用抗感染及对症疗法,2组均以14d为一个疗程。结果:合并蝮蛇抗栓酶组总有效率95％,单用对症疗法组为60％,组间比较(P<0.01)。

Blood hyperviscosity in 78 patients with pulmonary heart disease(M 58, F 20; age 59 ?10 a) was treated with heterotherapy combined Fushe Kangshuanmei 0.25 U/d or 0.5 U/d or 0.75 U/d in normal saline 250 mL iv gtt qd, 14 d as a course. Another 80 patients(M 57, F 23; age 61 ? a)with similar affection received heterotherapy to serve as control. Results showed that the total response rate was 95% and adverse effects were mild in the former group and 60% in the latter(P<0. 01).